RGEN Repligen Corporation
Healthcare$115.34+0.00%OpenMarket Cap: $6.51B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$163.14
Target (Median)
$160.00
Target Range
$142.00 - $200.00
Upside from current price: 41.4%
Rating Distribution
4 Strong Buy14 Buy4 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | JP Morgan | maintain | Overweight | Overweight |
| 2026-05-06 | Barclays | maintain | Overweight | Overweight |
| 2026-04-20 | Canaccord Genuity | maintain | Hold | Hold |
| 2026-04-06 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-03-23 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-25 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-02-25 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-02-25 | UBS | maintain | Buy | Buy |
| 2026-02-25 | Barclays | maintain | Overweight | Overweight |
| 2026-01-16 | UBS | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $2.59 | $945.3M | 11 |
| Sun Dec 31 | $3.28 | $1.09B | 5 |
| Mon Dec 31 | $4.31 | $1.25B | 1 |
| Tue Dec 31 | $5.44 | $1.44B | 1 |